Evolution of tumor cells during AsiDNA treatment results in energy exhaustion, decrease in responsiveness to signal, and higher sensitivity to the drug
Abstract It is increasingly suggested that ecological and evolutionary sciences could inspire novel therapies against cancer but medical evidence of this remains scarce at the moment. The Achilles heel of conventional and targeted anticancer treatments is intrinsic or acquired resistance following D...
Main Authors: | Pierre‐Marie Girard, Nathalie Berthault, Maria Kozlac, Sofia Ferreira, Wael Jdey, Srividya Bhaskara, Sergey Alekseev, Frederic Thomas, Marie Dutreix |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Evolutionary Applications |
Subjects: | |
Online Access: | https://doi.org/10.1111/eva.12949 |
Similar Items
-
AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance
by: Wael Jdey, et al.
Published: (2019-09-01) -
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
by: Nirmitha I. Herath, et al.
Published: (2019-11-01) -
Inhibition of DNA Repair by Inappropriate Activation of ATM, PARP, and DNA-PK with the Drug Agonist AsiDNA
by: Nathalie Berthault, et al.
Published: (2022-07-01) -
L’appropriation de la biomédecine en Asie du Sud-Est
by: Meriem M’zoughi
Published: (2021-11-01) -
The role of ABCC5 in the transport of inhibitory neuropeptides into vesicles
by: Broketa, M
Published: (2020)